Search
for
Sort by
Research 31–60 of 741
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- 9 Role of 5α-reductase in health and disease
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Two cases of low-prostate-specific antigen localized prostate cancer incidentally detected by computed tomography
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Androgen antagonists in androgen target tissues
- Cardiovascular effects of hormone therapy for prostate cancer
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- 25 years of ERβ: a personal journey
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment